Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018082
Filing Date
2025-06-24
Accepted
2025-06-24 16:25:38
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 form4-06242025_080635.html 4  
1 form4-06242025_080635.xml 4 3628
  Complete submission text file 0001415889-25-018082.txt   5005
Mailing Address 501 2ND STREET SUITE 211 SAN FRANCISCO CA 94107
Business Address
Seely Lynn (Reporting) CIK: 0001327111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 251069555

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)